Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Insulin Pump Market, by Product
1.4.2 North America Insulin Pump Market, by Disease Indication
1.4.3 North America Insulin Pump Market, by Distribution Channel
1.4.4 North America Insulin Pump Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Trials and Approvals
3.2.5 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
3.3.2 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2020, Feb – 2023, Mar) Leading Players
Chapter 4. North America Insulin Pump Market by Product
4.1 North America Pumps Market by Country
4.2 North America Insulin Pump Market by Pumps Type
4.2.1 North America Tethered Market by Country
4.2.2 North America Patch Market by Country
4.2.3 North America Others Market by Country
4.3 North America Consumables Market by Country
Chapter 5. North America Insulin Pump Market by Disease Indication
5.1 North America Type 1 Diabetes Market by Country
5.2 North America Type 2 Diabetes Market by Country
Chapter 6. North America Insulin Pump Market by Distribution Channel
6.1 North America Retail & Online Pharmacies Market by Country
6.2 North America Hospital Pharmacy Market by Country
Chapter 7. North America Insulin Pump Market by Country
7.1 US Insulin Pump Market
7.1.1 US Insulin Pump Market by Product
7.1.1.1 US Insulin Pump Market by Pumps Type
7.1.2 US Insulin Pump Market by Disease Indication
7.1.3 US Insulin Pump Market by Distribution Channel
7.2 Canada Insulin Pump Market
7.2.1 Canada Insulin Pump Market by Product
7.2.1.1 Canada Insulin Pump Market by Pumps Type
7.2.2 Canada Insulin Pump Market by Disease Indication
7.2.3 Canada Insulin Pump Market by Distribution Channel
7.3 Mexico Insulin Pump Market
7.3.1 Mexico Insulin Pump Market by Product
7.3.1.1 Mexico Insulin Pump Market by Pumps Type
7.3.2 Mexico Insulin Pump Market by Disease Indication
7.3.3 Mexico Insulin Pump Market by Distribution Channel
7.4 Rest of North America Insulin Pump Market
7.4.1 Rest of North America Insulin Pump Market by Product
7.4.1.1 Rest of North America Insulin Pump Market by Pumps Type
7.4.2 Rest of North America Insulin Pump Market by Disease Indication
7.4.3 Rest of North America Insulin Pump Market by Distribution Channel
Chapter 8. Company Profiles
8.1 Tandem Diabetes Care, Inc
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Acquisition and Mergers:
8.1.5.3 Trials and Approvals:
8.2 SOOIL Developments Co., Ltd
8.2.1 Company Overview
8.2.2 Recent strategies and developments:
8.2.2.1 Partnerships, Collaborations, and Agreements:
8.3 Jiangsu Delfu Medical Device Co.,Ltd
8.3.1 Company Overview
8.4 Medtronic PLC
8.4.1 Company overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Product Launches and Product Expansions:
8.4.5.2 Acquisition and Mergers:
8.4.5.3 Trials and Approvals:
8.4.6 SWOT Analysis
8.5 F. Hoffmann-La Roche Ltd.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Product Launches and Product Expansions:
8.6 Insulet Corporation
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Trials and Approvals:
8.6.5.3 Acquisition and Mergers:
8.6.5.4 Geographical Expansions:
8.7 Ypsomed AG
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Recent strategies and developments:
8.7.4.1 Partnerships, Collaborations, and Agreements:
8.8 Aetna, Inc. (CVS Pharmacy, Inc.)
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental Analysis
8.9 Diabeloop SA
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Partnerships, Collaborations, and Agreements:
8.10. APEX Medical Corporation
8.10.1 Company Overview
Unique Offerings 